Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

KRP vs VET: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KRP Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

KRP Overall Winner 6-Pillar Tally: KRP 3 – 3 VET Matrix Metrics: KRP 7 – 3 VET

As of Nov 20, 2026, Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests (KRP) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KRP carries a Unified Composite Score of 54.6/100 (HOLD) at $14.06 (14.4x Forward P/E, 38.0% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin).

  • Composite vs. Pillar Nuance: While VET currently prints a higher short-term Unified Composite Score (71.1/100 BUY vs. KRP 54.6/100 HOLD), KRP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (38.0% vs. -0.7% operating margin) and revenue trajectory (+28.9% vs. +30.4% YoY).
  • Technical & Structure Timing Caution: KRP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 28.2); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KRP vs VET
KRP NYSE Head-to-Head Winner
Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests
Crude Petroleum & Natural Gas
$14.06
-0.57% 1D
Market Cap $2.1B
TTM Revenue $367M
Forward P/E 14.4x
Beta / 30D Vol -0.29β · 30% Vol
Unified Composite Score
54.6 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 28
RSI-14: 28.2 · SMA20: $15.55 · SMA50: $15.33
VET NYSE
Vermilion Energy Inc.
Crude Petroleum & Natural Gas
$10.25
-1.06% 1D
Market Cap $1.6B
TTM Revenue $1.97B
Forward P/E 17.4x
Beta / 30D Vol -0.77β · 61% Vol
Unified Composite Score
71.1 / 100 BUY
Tech 84.0 Fund 71.0 Flow 56.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.7%), weak momentum, RSI 33
RSI-14: 33.5 · SMA20: $11.53 · SMA50: $12.01

6-Pillar Scorecard Institutional Category Breakdown (KRP 3 – 3 VET)

Columns: Metric · KRP · VET
1. Valuation Multiples KRP
Forward P/E 14.4x 17.4x
Trailing P/E 18.0x 17.4x
PEG Ratio 2.60x 3.58x
EV / Revenue 5.7x 1.4x
2. Growth & Scale VET
Revenue Growth (YoY) +28.9% +30.4%
Earnings Growth (YoY) -35.7% -94.9%
TTM Revenue (USD) $367M $1.97B
Market Cap $2.1B $1.6B
3. Profitability & Quality KRP
Gross Margin 93.1% 64.0%
Operating Margin 38.0% -0.7%
Net Profit Margin 23.0% -24.6%
Return on Equity (ROE) 11.2% -20.1%
4. Balance Sheet & Cash Flow KRP
Cash Generation (TTM) $264M EBITDA $1.31B
Cash Flow Margin 71.8% EBITDA Mgn 66.5%
Net Cash / Leverage $6.29 Book/Sh · 11.2% ROE $1.18B Net Debt (0.59x D/E)
Dividend Yield 12.03% 5.20%
5. Options & Positioning VET
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 16.2% (1st %ile) 46.5% (23rd %ile)
Put/Call OI Skew N/A 0.30x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat VET
OpEx & R&D Intensity 55.1% of Rev ($202M) 64.7% of Rev ($1.27B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Oil & Gas E&P Operator Oil & Gas E&P Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KRP (7) vs VET (3)
Institutional Metric KRP VET Criterion Row Edge
Market Capitalization
Scale
$2.1B $1.6B Larger Scale KRP
Trailing P/E Ratio
Valuation
18.0x 17.4x Lower Multiple VET
Forward P/E Ratio
Valuation
14.4x 17.4x Lower Multiple KRP
Revenue Growth (YoY)
Growth
+28.9% +30.4% Higher Growth VET
Operating Margin (TTM)
Profitability
38.0% -0.7% Higher Margin KRP
Net Profit Margin
Profitability
23.0% -24.6% Higher Margin KRP
Return on Equity (ROE)
Capital Efficiency
11.2% -20.1% Higher ROE KRP
52-Week Range Position
Momentum
47% ($11–$17) 35% ($8–$15) Stronger Trend KRP
Beta / 30D Volatility
Risk Regime
-0.29β · 30% Vol -0.77β · 61% Vol Lower Realized Risk KRP
Unified Institutional Score
Composite Signal
54.6 / 100 (HOLD) 71.1 / 100 (BUY) Higher Composite VET
Trailing 12M Revenue (USD)
Operating Scale
$367M $1.97B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
93.1% 64.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.60x PEG · 5.7x EV/Rev 3.58x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$264M EBITDA ($6.29 Book/Sh · 11.2% ROE) $1.31B ($1.18B Net Debt (0.59x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KRP +9.11 pp
KRP: -14.68% · VET: -23.79%
3M Horizon KRP +9.2 pp
KRP: -9.06% · VET: -18.26%
6M Horizon KRP +9.23 pp
KRP: -7.44% · VET: -16.67%
1Y Horizon VET +4.94 pp
KRP: +6.35% · VET: +11.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KRP vs VET. Trailing 12-month operating profitability (KRP 38.0% vs VET -0.7%) and valuation multiples (KRP 14.4x vs VET 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.

KRP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$367M
Gross Margin93.1%
Op. Margin38.0%
ROE / Fwd P/E11.2% · 14.4x
VET ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.97B
Gross Margin64.0%
Op. Margin-0.7%
ROE / Fwd P/E-20.1% · 17.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KRP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 16.2%
IV Percentile 1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KRP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VET CONSOLIDATION
48d in phase · OBV NEUTRAL
Current IV 46.5%
IV Percentile 23rd %ile
Put/Call OI Skew 0.30x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KRP Moat Profile High-Margin Pricing Power Moat
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $2.1B market capitalization and 38.0% operating margin.
OpEx & R&D Reinvestment 55.1% of Rev ($202M)
90D Engineering Disclosures 0 Published
VET Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.6B market capitalization and -0.7% operating margin.
OpEx & R&D Reinvestment 64.7% of Rev ($1.27B)
90D Engineering Disclosures 0 Published

Investor FAQ KRP vs VET Key Questions & Quantitative Answers

As of Nov 20, 2026, Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests (KRP) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KRP carries a Unified Composite Score of 54.6/100 (HOLD) at $14.06 (14.4x Forward P/E, 38.0% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin). Composite vs. Pillar Nuance: While VET currently prints a higher short-term Unified Composite Score (71.1/100 BUY vs. KRP 54.6/100 HOLD), KRP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (38.0% vs. -0.7% operating margin) and revenue trajectory (+28.9% vs. +30.4% YoY). Technical & Structure Timing Caution: KRP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 28.2); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VET leads the Growth & Scale pillar: KRP posts +28.9% YoY revenue growth and -35.7% YoY earnings growth on $367M TTM revenue (93.1% gross margin, 38.0% operating margin), compared with VET at +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin). On trailing 12-month operating scale, KRP generates $367M in USD-normalized revenue versus $1.97B for VET. In operating R&D and SG&A reinvestment, KRP deploys 55.1% of Rev ($202M) (0 90-day corporate R&D disclosures) versus 64.7% of Rev ($1.27B) (0 disclosures) for VET.

KRP screens cheaper on headline valuation multiples. KRP trades at 14.4x Forward P/E, 18.0x Trailing P/E, 2.60x PEG, and 5.7x EV/Revenue (71.8% EBITDA margin), whereas VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KRP (11.2% ROE) versus VET (-20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, KRP carries 16.2% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.29β · 30% Vol realized risk). By comparison, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.